Evaluation of point-of-care coagulation tests as alternatives to anti-Xa activity for monitoring the anticoagulant effects of rivaroxaban in healthy dogs.

Alex M LynchLaura K RuterboriesEmily H GriffithRita M HanelAlyssa P StableinMarjory B Brooks

Published in: Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001) (2020)

Of all the coagulation tests investigated, the PT correlated best with RIVA. There is potential for PT being a convenient second-line monitoring option in dogs receiving rivaroxaban, but further work is necessary to validate other PT assays. Thromboelastography performed with strong activators correlated poorly with anti-Xa activity.

Keyphrases

venous thromboembolism
atrial fibrillation
pulmonary embolism
high throughput
single cell